DiethelmKellerSiberHegner (DKSH), a Swiss market expansion services provider, announced the successful transfer of its healthcare business in China.

DKSH, in accordance with its increased strategic focus and in the context of a recent portfolio review, identified U.S.-based private equity firm Warburg Pincus as the ideal new owner.

Warburg Pincus’ scale and experience will allow DKSH to further take advantage of the potential in the business. The transaction includes DKSH’s pharmaceuticals, consumer health and medical device businesses in China.

The purchase price is approximately 100 million francs ($99.8 million). DKSH will deconsolidate the business starting from November.